Latest news with #ButterflyNetwork
Business Wire
22-05-2025
- Business
- Business Wire
Butterfly Network to Participate at William Blair 45th Annual Growth Stock Conference
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ('Butterfly') a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that Joseph DeVivo, President, Chief Executive Officer and Chairman will present and host one-on-one investor meetings at William Blair 45th Annual Growth Stock Conference. The presentation will take place on Thursday, June 5, 2025, at 8:00 am CT in Chicago, IL. A live webcast of the presentation will be available in the Events & Presentations section of the Butterfly investor website, and available for replay following the event. To schedule a one-on-one meeting with Mr. DeVivo, please reach out to your William Blair representative. About Butterfly Network Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world's first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore's Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly's innovations have also been recognized by Fierce 50, TIME's Best Inventions and Fast Company's World Changing Ideas, among other achievements. Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit:
Yahoo
10-05-2025
- Business
- Yahoo
Butterfly Network, Inc. (BFLY): Among Billionaire Larry Robbins' Stock Picks with Huge Upside Potential
We recently published a list of Billionaire Larry Robbins' 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Butterfly Network, Inc. (NYSE:BFLY) stands against other stock picks with huge upside potential. Larry Robbins is an American hedge fund manager and philanthropist who founded Glenview Capital Management in 2000. The firm manages capital for investors across a range of private investment funds. Robbins is currently the CEO of his firm. He graduated with honors from the Jerome Fisher Program in Management and Technology at the University of Pennsylvania in 1992 and earned a BS in economics with concentrations in accounting, finance, and marketing. He also has a BS in engineering with a major in systems engineering. He became a Certified Public Accountant in Illinois in 1991. Before founding Glenview Capital, Robbins worked as a portfolio manager at Omega Advisors, which is a prominent hedge fund founded by Leon Cooperman. In 2017, Larry Robbins also began serving as chairman of the Robin Hood Foundation, which fights poverty in New York City. Through his Family Foundation, he is an active supporter of education reform both in NYC and on the national level. He also serves as Chairman of the Board of KIPP NY and is a Board Member of Zearn and Relay Graduate School of Education. Due to his sharp analytical skills and a focus on the healthcare sector, Robbins has built a reputation as one of the most influential figures in the hedge fund industry. Glenview Capital Management has 6 clients and discretionary assets under management (AUM) of $5.6 billion as reported in its Form ADV dated 4 March 2025. The last reported 13F filing for Q4 2024 included $3.95 billion in managed 13F securities and a top 10 holdings concentration of 65.22%. Earlier in September 2024, Institutional Investor reported that Glenview Capital Management was on track for its best year in 5 years. The flagship Glenview Capital Partners fund was up 3.45% in August 2024 and 17.2% through the first 8 months of the year. One of the reasons behind this performance is the hedge fund's diversification away from a historically heavy concentration in healthcare stocks. Glenview Capital Management has now expanded its investments into the tech sector and other industries. Larry Robbins believes in a straightforward investment strategy: 'There are only two things that matter in investing. What are they going to earn, and what multiple are people going to put on that. Let's not make our business any more complicated than this.' To compile the list of billionaire Larry Robbins' 10 stock picks with huge upside potential, we sifted through Q4 2024 13F filings of Glenview Capital from Insider Monkey. From these filings, we checked the upside potential from CNN for the top 30 stock picks and ranked the stocks in ascending order of this upside potential. We have also added Glenview Capital's stake in each stock as well as the broader hedge fund sentiment for it. Note: All data was sourced on May 8. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here). A doctor looking at a ultrasound system with a Compass software interface, demonstrating the sophistication of the device. Glenview Capital's Stake: $31.06 million Number of Hedge Fund Holders: 26 Average Upside Potential as of May 5: 83.49% Butterfly Network, Inc. (NYSE:BFLY) develops, manufactures, and commercializes ultrasound imaging solutions. It offers the Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow. These are accessible on a user's smartphone, tablet, and almost any hospital computer system. In Q1 2025, Butterfly's core Point-of-Care Ultrasound/POCUS business benefited from the typical influx of medical school opportunities. The company is transitioning medical schools from shared laboratory probes to individual probes purchased by each student. One of the largest colleges of osteopathic medicine committed to this model and order one probe per student going forward. Financially, the US sales channels at Butterfly Network, Inc. (NYSE:BFLY), influenced by these medical school opportunities, saw a 24% revenue increase in Q1, which contributed to the overall 20% growth and $21.2 million in revenue. Product revenue, which was driven by higher sales volume in this segment and the higher selling price of the iQ3 probe, also increased by 25% to $14.2 million. Overall, BFLY ranks 3rd on our list of billionaire Larry Robbins' stock picks with huge upside potential. While we acknowledge the potential of BFLY as an investment, our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than BFLY but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24-04-2025
- Business
- Yahoo
Is Butterfly Network, Inc. (BFLY) the Best Multibagger Penny Stock to Buy According to Billionaires?
We recently published a list of . In this article, we are going to take a look at where Butterfly Network, Inc. (NYSE:BFLY) stands against other best multibagger penny stocks to buy according to billionaires. Penny stocks always seem like bargains for gaining exposure to some of the fastest-growing segments or spectacles, especially when popular stocks cost hundreds or thousands of dollars. Given that some cost as little as $2, they can be tempting for growing money quickly without spending much. While it's possible to achieve significant returns while investing in companies with depressed stock prices, caution is always of utmost importance. Low-priced stocks come with elevated levels of volatility as reduced liquidity makes them speculative, high-risk investments. Over the years, massive penny-stock scams have cheated thousands of investors out of millions of dollars, even as others have generated a fortune out of them. 2024 was one such year where investors betting on penny stocks generated a fortune as the overall stock market remained bullish. Explosive gains came into play as the equity outlook improved on expectations that the US Federal Reserve would cut interest rates. Amid the current correction in the equity market after two years of blockbuster gains, penny stocks are increasingly becoming popular owing to their depressed valuations. President Donald Trump's eldest son, Donald Trump Jr., and Lara Trump have already joined the fray in acquiring significant stakes in a conservative radio network, affirming renewed interest in thinly traded companies. Nevertheless, in the face of rising trade tensions and the lowest consumer confidence seen in almost three years, US markets have faced significant fluctuations. Yet, despite these obstacles, the idea of penny stocks continues to hold relevance as investors hunt for low-cost options with potential for growth. Often linked with smaller or emerging companies, these stocks can present considerable upside when supported by robust financials and sound fundamentals. It is possible to realize impressive returns by investing money into young firms with small market valuations or undervalued stock prices. That is especially the case at a time when President Trump is increasingly pushing for lower interest rates in the US. Like large-cap stocks, penny stocks tend to do well in low-interest rates environments as acquiring capital to accelerate operations and generate shareholder value becomes easier and more affordable for new and emerging companies. For this article, we used a stock screener first to identify stocks priced under $5 that have posted huge gains over the past year (at least 100%). From the obtained dataset, we selected penny stocks with the highest percentage gains in stock performance over the past year (as of April 21). The list is ranked based on the number of billionaires that hold stakes in them, the data for which we sourced from Insider Monkey's proprietary database. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). A doctor looking at a ultrasound system with a Compass software interface, demonstrating the sophistication of the Network, Inc. (NYSE:BFLY) is a healthcare company that develops and markets affordable, accessible medical imaging tools. Its core technology is the 'Ultrasound-on-Chip™' enabling the creation of a single-probe, whole-body ultrasound system. The stock has rallied by 225% over the past year amid growing expectations that robust revenue growth will propel it to profitability. On March 17, William Blair initiated coverage of the stock with an Outperform recommendation. Butterfly Network, Inc. (NYSE:BFLY) delivered record revenue of $22.4 million in Q4 2024, representing 35% year-over-year growth. Butterfly Network's transition to the more profitable iQ3 device was the catalyst behind product revenue increasing 45% year-over-year. It also successfully reduced its net loss by 59% to $18.1 million. Butterfly Network has laid up strategic plans to meet long-term financial goals. These include achieving a $500 million revenue goal in five years and cash flow breakeven by 2027. One of these strategic moves is establishing a new company, Octiv, to market ultrasound technology in new industries. With $92.8 million in cash, the company remains in a strong financial position to invest in key growth strategies. Overall, BFLY ranks 6th on our list of best multibagger penny stocks to buy according to billionaires. While we acknowledge the potential of BFLY as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than BFLY but that trades at less than 5 times its earnings check out our report about the . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
02-04-2025
- Business
- Yahoo
Butterfly iQ3 Ultrasound Featured in HBO Max's The Pitt Episodes 12 and 13
Mainstream television use of Butterfly's handheld ultrasound technology highlights its growing role in real-life patient care. BURLINGTON, Mass. & NEW YORK, April 02, 2025--(BUSINESS WIRE)--Butterfly Network, Inc. ("Butterfly" or the "Company") (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, shared that its Butterfly iQ3 ultrasound device was featured in Episodes 12 and 13 of the popular HBO Max medical drama The Pitt. The show has gained a significant following, including among healthcare professionals, given its realistic and compelling depiction of modern medical practices. In the featured episodes, Butterfly Network's handheld ultrasound devices are used extensively by the medical staff in a trauma triage setting. A pivotal episode showcases a mass casualty event in which the series lead Noah Wyle, playing the head of the ED, Dr. Michael "Robby" Robinavitch, orders the removal of traditional cart-based ultrasound equipment due to space limitations. In doing so, emphasizing the importance of mobile and efficient diagnostic tools like Butterfly. Throughout the episodes, the devices are utilized for critical assessments including EFAST exams, blood flow evaluations, and internal bleeding detection. In the latest episode, Butterfly is used to assess intracranial pressure, demonstrating its versatility in emergency and trauma care settings when used by both experienced and novice practitioners. "This feature in The Pitt is a clear demonstration that point-of-care ultrasound is at a tipping point in healthcare," commented Joseph DeVivo, President, Chief Executive Officer and Chairman of Butterfly Network. "What we're seeing on screen is not just TV drama—this is happening across the country and globally. We have devices in all 100 of the top 100 U.S. health systems, and the adoption of this technology is accelerating at a pace that's benefiting patients everywhere." Jennifer Huang, Butterfly Network's Vice President of Marketing, added, "When we were asked by the production team to provide an iQ3 probe for the show, we didn't know what to expect from an unpaid placement. The level of visibility and usage of our product in the series is a testament to the tremendous value of Butterfly's technology and a demonstration that Butterfly is becoming the standard for handheld ultrasound. It's more than just a brand name; Butterfly is now a verb used among clinicians. It's exciting to see how the healthcare community is increasingly recognizing its critical impact on patient care." The prominent placement of Butterfly iQ3 in The Pitt highlights the growing adoption of POCUS technology in real-world healthcare environments – a trend not just in trauma and emergency care but expanding across specialties. Butterfly's portable ultrasound solutions are transforming the way medical professionals diagnose and treat patients at the point of care, empowering providers to deliver faster, more accurate assessments and improving patient outcomes. For more information about Butterfly's technology and its impact on healthcare, visit About Butterfly Network Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world's first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore's Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly's innovations have also been recognized by Fierce 50, TIME's Best Inventions and Fast Company's World Changing Ideas, among other achievements. Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: View source version on Contacts Butterfly Media:Liz LearnedHead of Communications & PR, Butterflymedia@ Butterfly Investors:Heather GetzChief Financial and Operations Officer, Butterflyinvestors@ Sign in to access your portfolio
Associated Press
21-02-2025
- Business
- Associated Press
Butterfly Network to Participate at the TD Cowen 45th Annual Health Care Conference on March 3, 2025
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Feb 21, 2025-- Butterfly Network, Inc. (NYSE: BFLY) ('Butterfly') a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will present and host one-on-one investor meetings at the TD Cowen 45th Annual Health Care Conference in Boston on March 3, 2025. Heather Getz, Executive Vice President & Chief Financial and Operations Officer will host one-on-one meetings and will present a business overview at 1:10pm EST. A webcast of the presentation will be available in the Events & Presentations section of the Butterfly investor website. About Butterfly Network Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world's first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore's Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly's innovations have also been recognized by Fierce 50, TIME's Best Inventions and Fast Company's World Changing Ideas, among other achievements. Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world's first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore's Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly's innovations have also been recognized by Fierce 50, TIME's Best Inventions and Fast Company's World Changing Ideas, among other achievements. Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: . Heather Getz Chief Financial and Operations Officers, Butterfly [email protected] Halper LifeSci Advisors (IR Representative) 646-876-6455 SOURCE: Butterfly Network, Inc. Copyright Business Wire 2025. PUB: 02/21/2025 08:05 AM/DISC: 02/21/2025 08:04 AM
